United Therapeutics Stock
United Therapeutics Stock
United Therapeutics dominated the market today, gaining €21.70 (9.880%).
With 18 Buy predictions and not the single Sell prediction the community is currently very high on United Therapeutics.
With a target price of 288 € there is a slightly positive potential of 19.55% for United Therapeutics compared to the current price of 240.9 €.
Pros and Cons of United Therapeutics in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | 9.880% | 9.500% | 13.525% | 16.433% | 21.513% | 41.706% | 169.825% |
| Ironwood Pharmaceuticals | 0.690% | -3.333% | -8.805% | -22.043% | -28.922% | -21.622% | - |
| Sage Therapeutics Inc. | -3.520% | -3.667% | -23.728% | -70.207% | -38.925% | -81.156% | - |
| Novocure Ltd | 8.240% | 15.965% | -1.196% | -77.601% | -7.391% | -92.217% | - |
Comments
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $375.00 to $400.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for UTHR provided by MarketBeat